TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.54
-0.06 (-4.05%)
At close: May 01, 2025, 3:59 PM
1.55
0.59%
After-hours: May 01, 2025, 04:20 PM EDT
TScan Therapeutics Revenue
TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending December 31, 2024, TScan Therapeutics generated $665K in revenue.
Revenue (ttm)
$2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
$14.52K
Employees
194
Market Cap
87.2M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|